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Abstract 26 
Background  27 
Gambian sleeping sickness or HAT (human African trypanosomiasis) is a neglected tropical 28 
disease caused by Trypanosoma brucei gambiense transmitted by riverine species of tsetse. A 29 
global programme aims to eliminate the disease as a public health problem by 2020 and stop 30 
transmission by 2030. In the South of Chad, the Mandoul area is a persistent focus of 31 
Gambian sleeping sickness where around 100 HAT cases were still diagnosed and treated 32 
annually until 2013. Pre-2014, control of HAT relied solely on case detection and treatment, 33 
which lead to a gradual decrease in the number of cases of HAT due to annual screening of 34 
the population. 35 
Methods 36 
Because of the persistence of transmission and detection of new cases, we assessed whether 37 
the addition of vector control to case detection and treatment could further reduce 38 
transmission and consequently, reduce annual incidence of HAT in Mandoul. In particular, 39 
we investigated the impact of deploying ‘tiny targets’ which attract and kill tsetse. Before 40 
tsetse control commenced, a census of the human population was conducted and their 41 
settlements mapped. A pre-intervention survey of tsetse distribution and abundance was 42 
implemented in November 2013 and 2600 targets were deployed in the riverine habitats of 43 
tsetse in early 2014, 2015 and 2016. Impact on tsetse and on the incidence of sleeping 44 
sickness was assessed through nine tsetse monitoring surveys and four medical surveys of the 45 
human population in 2014 and 2015. Mathematical modelling was used to assess the relative 46 
impact of tsetse control on incidence compared to active and passive screening. 47 
Findings 48 
The census indicated that a population of 38674 inhabitants lived in the vicinity of the 49 
Mandoul focus. Within this focus in November 2013, the vector is Glossina fuscipes fuscipes 50 
and the mean catch of tsetse from traps was 0.7 flies/trap/day (range, 0-26). The catch of 51 
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tsetse from 44 sentinel biconical traps declined after target deployment with only five tsetse 52 
being caught in nine surveys giving a mean catch of 0.005 tsetse/trap/day. Modelling 53 
indicates that 70.4% (95% CI: 51-95%) of the reduction in reported cases between 2013 and 54 
2015 can be attributed to vector control with the rest due to medical intervention. Similarly 55 
tiny targets are estimated to have reduced new infections dramatically with 62.8% (95% CI: 56 
59–66%) of the reduction due to tsetse control, and 8.5% (95% 8–9%) to enhanced passive 57 
detection. Model predictions anticipate that elimination as a public health problem could be 58 
achieved by 2018 in this focus if vector control and screening continue at the present level 59 
and, furthermore, there may have been virtually no transmission since 2015.  60 
Conclusion 61 
This work shows that tiny targets reduced the numbers of tsetse in this focus in Chad, which 62 
may have interrupted transmission and the combination of tsetse control to medical detection 63 
and treatment has played a major role in reducing in HAT incidence in 2014 and 2015. 64 
Keywords: Chad - Mandoul focus - Human African Trypanosomiasis- tsetse control- 65 
transmission- mathematical modelling -  66 
 67 
 68 
Author summary 69 
A global programme aims to eliminate Gambian sleeping sickness (Human African 70 
Trypanosomiasis, HAT) as a public health problem by 2020.  Gambian HAT is a neglected 71 
tropical disease caused by trypanosomes spread by tsetse flies and its control has relied 72 
largely on detection and treatment of human cases.  In the Mandoul focus of southern Chad, 73 
regular screening of the human population (~39000 people) between 2002 and 2013 resulted 74 
in the detection and treatment of ~100 cases/year.  We examined whether even better control 75 
might be achieved through the addition of vector control to medical screening.  In February 76 
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2014, 2600 insecticide-treated targets (‘Tiny Targets’) were deployed in areas where tsetse 77 
were present; tsetse are attracted to the targets and on contacting it they pick up a lethal dose 78 
of insecticide.  Monitoring of the tsetse population, using a network of 44 traps operated 79 
regularly between November 2013 and October 2016, showed that the mean daily catch of 80 
tsetse declined by 99.99%, from 0.7 tsetse/trap before targets were deployed to 0.005 81 
tsetse/trap.  The number of HAT cases detected by a programme of active screening also 82 
declined during this period.  Mathematical modelling of the number of HAT cases reported 83 
during the period 2000-2015 suggests that 70% of the decline in cases during 2014-2015 was 84 
due to vector control.  The model also suggests that the combination of these interventions 85 
may have interrupted transmission and may to lead to the elimination of sleeping sickness in 86 
the Mandoul focus by 2020. The results from Mandoul provide further empirical and 87 
theoretical evidence that the global elimination of Gambian HAT can be achieved through the 88 
integrated use of (i) case detection and treatment and (ii) vector control.    89 
90 
	 5	
Introduction 91 
Human African Trypanosomiasis (HAT), also called sleeping sickness, is an endemic 92 
neglected tropical disease found in sub-Saharan Africa, caused by subspecies of Trypanosoma 93 
brucei transmitted by tsetse flies (Glossina). There is no vaccine against this lethal disease, 94 
and treatment is difficult with 1–2 weeks hospitalisation for drug treatment [1]. Most (>97%) 95 
cases of HAT are caused by T. brucei gambiense. The WHO roadmap aims to eliminate 96 
Gambian HAT as a public health problem by 2020 and reach full elimination globally by 97 
2030 [2]. 98 
Mass screening of populations followed by diagnosis and treatment of cases has been the 99 
main method used to control Gambian HAT. These mass-screening programmes, combined 100 
with passive surveillance, have saved lives and have led to a dramatic reduction of the annual 101 
reported incidence of Gambian HAT, from > 37,000 cases/year in 1998 to <3,000 cases/year 102 
in 2015  [1, WHO Global Health Observatory data repository: 103 
http://apps.who.int/gho/data/node.main.A1636?lang=en)]. Nonetheless some foci persist 104 
despite mass screening of populations [3, 4].  105 
The recent development and successful application of cost-effective methods - particularly so-106 
called ‘tiny targets’ [5, 6] - offers the exciting prospect of a method that can reduce densities 107 
of tsetse in HAT foci and contribute, in association with medical interventions, to the 108 
interruption of transmission [7, 8].  109 
An example of a persistent focus is the case of Mandoul in Southern Chad. Here, 110 
notwithstanding the progress achieved during several years of active "screen and treat" 111 
programmes, and passive surveillance, often with high coverage, the number of HAT cases 112 
reported greatly exceeded the threshold for elimination as a public health problem. In 2014, 113 
we implemented a tsetse control programme to determine whether reducing the numbers of 114 
tsetse could reduce the incidence of HAT. The entomological intervention itself was 115 
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conducted using insecticide-impregnated targets that kill tsetse, whilst monitoring of vector 116 
densities was performed using traps that catch and retain the flies. 117 
 118 
Material and Methods 119 
 120 
Ethical statement 121 
The Ministry of Health of the Republic of Chad approved the study protocols and gave 122 
administrative authorizations for the activities performed by the National Control Programme 123 
against HAT (PNLTHA: Programme National de Lutte contre la Trypanosomiase Humaine 124 
Africaine). Mass screening and treatment of HAT patients were performed according to the 125 
national Chadian HAT procedures as recommended by the World Health Organization. 126 
Information on HAT, on tsetse and tsetse control using targets and the study objectives was 127 
provided directly to individual households and more broadly via radio broadcasts (Ngor, 128 
Arab, French languages) and discussion groups organized with the Bodo district health 129 
authorities, village administrations and religious groups. Consent to participate was oral and 130 
was not mandatory. All activities were made according to the national rules of the Ministry of 131 
Health in Chad, through the national program against HAT (PM, coordinator of the NCP is 132 
one of the co-authors of the paper). These national rules do not involve written consent. 133 
All data of the paper from participants were recorded as numbers, so anonymized, from the 134 
national program. 135 
No human biological samples other than those required for HAT diagnosis were taken from 136 
participants in the course of this study. 137 
 138 
Study area 139 
The study was performed in the Mandoul focus (ca. 8.12oN, 17.11oE) located in Southern 140 
Chad, close to the border with the Central African Republic (CAR). The study area covered 141 
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part of Bodo, Beboto, Koldaga, Dilingala and Bekourou cantons and is about 840 km2. In this 142 
area, the mean elevation is ~400 meters and annual rainfall is between 1000 and 1200 143 
mm/year, with two seasons: a wet season from June to October and a dry season from 144 
November to May. The landscape is characterized by woody savannah with gallery forest 145 
along the rivers. The natural vegetation is degraded in parts through agriculture activities. 146 
Within the focus lies a swamp. People pass through the swamp in the course of their daily 147 
activities. The local population comprise Ngor who are sedentary mixed crop-livestock 148 
farmers and also Arab and M’bororo (pastoralist livestock keepers). The numbers of the latter 149 
vary according to season and the availability of water and grazing in the region. Activities that 150 
bring the population into areas where tsetse are present include the cultivation of crops 151 
(sorghum, sesame, sweet potatoes), fishing, collection of wood and beekeeping. The Mandoul 152 
area is a historical focus of sleeping sickness. It was included in the “secteur de prophylaxie 153 
numéro 3” created in 1919 and was visited by the medical teams led by Gaston Muraz in 1928 154 
[9, 10]. Two species of tsetse were historically recorded in the area: Glossina fuscipes 155 
fuscipes and Glossina morsitans submorsitans [11, 12]. 156 
 157 
Mapping the human population 158 
A census of the human population was conducted in 2013 to quantify the number of people 159 
and their geographical distribution. The number of persons living in households was recorded 160 
and the location recorded using a Global Positioning System (Garmin 64s). For each 161 
household, the name of the head person and the number of inhabitants were recorded. The 162 
main roads, tracks and paths leading between settlements and towards the swamp were 163 
mapped, as well as the routes used to cross the swamp. 164 
 165 
“T0” Entomological baseline survey 166 
Prior to the beginning of the tsetse control campaign, entomological baseline data were 167 
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collected in November 2013 using 108 biconical traps deployed for 48 hours. Along the banks 168 
of the Mandoul River, traps were set in pairs, with each trap being at least 100 m apart and 169 
pairs of traps deployed at intervals of ~2 km. In addition, traps were also arranged in a 170 
transect running from the riverbank to the savannah where possible. Traps were also deployed 171 
at several jetties which were likely to be sites of human-tsetse contact.  172 
 173 
Target deployment 174 
Tiny targets comprising 0.25m × 0.25m blue polyester flanked by 0.25m × 0.25m black 175 
polyethylene netting [6] impregnated with deltamethrin at 300mg/m2 were used to kill but not 176 
monitor tsetse. Targets were obtained commercially from Vestergaard-Frandsen (Lausanne, 177 
Switzerland). They were deployed in the forest gallery along the Mandoul River, in places 178 
frequented by people identified during the population census and where tsetse were caught 179 
during the pre-intervention survey. Tsetse were detected over a limited range along the 180 
Mandoul but targets were deployed up to 4 km beyond where tsetse were caught. The first 181 
deployment was done in January - February 2014, and all targets were replaced at the same 182 
period in 2015 and 2016. Targets were suspended from tree branches at 10-20 cm above the 183 
ground, using string, or erected with wooden sticks obtained locally (Fig 1). 184 
 185 
Figure 1: A tiny target suspended from a branch.  186 
Tsetse collide with the deltamethrin-treated target and pick up a lethal dose of insecticide [3, 187 
8]. 188 
 189 
Entomological monitoring 190 
Entomological monitoring was done using 44 geo-referenced sentinel traps which were 191 
selected according to both geographical coverage of the area and tsetse presence in the traps 192 
during the T0 survey. These sentinel traps were deployed for 48 h continuously at every 193 
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monitoring survey to allow comparison between surveys unless stated otherwise. 194 
Nine monitoring surveys (T1-T9) were implemented to assess changes in the catch of tsetse 195 
within the study area: the first one was undertaken in April-May 2014, 2-3 months after the 196 
deployment of targets, and thereafter during the months of March, May and October of the 197 
two following years (2015-2016). During the fourth and fifth surveys (T4, T5) respectively, 198 
additional traps and sticky traps (standard traps with the blue attractive part wrapped with 199 
transparent adhesive film; [13]) were deployed at sites where relatively high numbers of tsetse 200 
were caught during the T0 survey, in order to increase probability of catching tsetse. For the 201 
same purpose, traps were operated continuously for six consecutive days instead of the usual 202 
two during the sixth survey (T6).  All surveys conducted in 2016 (T7-T9) reverted to the 203 
standard protocol with traps being operated for 48 h.  204 
 205 
Medical surveys  206 
Data on HAT cases were obtained through the WHO HAT Atlas for 2000–2014 [4, 14] and 207 
also through the PNLTHA of the Republic of Chad for 2015. These epidemiological data 208 
come from both passive surveillance and active screening activities. Passive detection relies 209 
on self-presentation of symptomatic people to medical facilities. HAT cases were detected 210 
and treated according to the WHO algorithm [15], slightly modified [16] in order to allow 211 
examination of up 1500 people per day by active screening. These modifications essentially 212 
involved splitting of the medical team to examine more people. First, all screened people were 213 
tested with CATT (card agglutination test for trypanosomiasis) on whole blood, the negatives 214 
were released, and serum was taken from the positives. People positive for the CATT test 215 
done on serum up to 1/4 dilution but negative at 1/8 were released and considered as 216 
serological suspects. Parasitological examination consisted of capillary tube centrifugation 217 
(CTC), and/or direct examination of lymph nodes aspirates. 218 
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All the positive individuals to at least 1/8 dilution of the CATT test, but parasitologically 219 
negative (meaning no trypanosome detected) were considered as serological cases. 220 
Serological cases, as well as parasitological ones, where trypanosomes were observed directly 221 
through microscopic examination of blood and/or cerebrospinal fluid, were then treated with 222 
pentamidine for infections considered to be first stage, and with Nifurtimox and Eflornithine 223 
combination (NECT) for those in the second stage. Stage diagnosis was done using lumbar 224 
puncture and cerebrospinal fluid examination. In 2015 surveillance was enhanced in the 225 
Mandoul region by improving the capacity for passive screening through equipping health 226 
facilities with rapid diagnostic tests (RDTs) and upgrading confirmation and treatment centres 227 
[17].    228 
 229 
Statistical analysis 230 
Comparison of catches of tsetse from traps during the different monitoring periods were 231 
analysed using a collection of generalised linear mixed-effects models (GLMEs), with 232 
Poisson error distributions and log link functions [18]. Trap sites (n=44) were grouped into 15 233 
different spatial locations. A baseline fixed effect was associated with each spatial location. 234 
Climatic predictors considered were precipitation and temperature and the study design was 235 
included via an indicator for tiny target (intervention) deployment and the duration of 236 
monitoring trap deployment. Trap level random effects and overdispersion were considered in 237 
the models.   The best model was selected to be the one with the lowest corrected Akaike 238 
Information Criterion (AICc) and also we considered others within 2 AICc as competing 239 
hypotheses [19, 20]. All statistical analyses were carried out using the MATLAB 2015a 240 
fitglme package. 241 
Modelling analysis 242 
In order to determine the unobservable impact of vector control upon the incidence of new 243 
infections, a previously developed mathematical model [21, 22] for Gambian HAT was 244 
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modified. The mechanical model tracks human hosts in their various stages of HAT infection 245 
including stage 1 and stage 2 disease, as well as infection prevalence in the tsetse population 246 
(Fig SI and Eq S1.1). The model was fitted to the available epidemiological human case data 247 
using Metropolis Hastings MCMC to estimate the unknown parameters specific to this region, 248 
which include tsetse-human ratio, passive detection rate of stage 1 cases and underreporting. 249 
Model outputs of cases were stratified by their detection method (active/passive) in order to 250 
match to the data. Since infection prevalence in tsetse was unknown this could not be used for 251 
fitting, but the model can be used to provide an estimate of tsetse prevalence based on 252 
knowledge of the tsetse-host transmission cycle and fitting to the human data (Fig S2). Case 253 
data from 2000–2013 was used to fit the model, while 2014 and 2015 were predicted based on 254 
known active screening levels continued passive surveillance and tsetse population reduction. 255 
These years were therefore used as validation years to test the predictive ability of the model.  256 
 257 
In 2015, passive surveillance was expanded by equipping health facilities with new diagnostic 258 
tools. To account for this step-change in passive strategy in the model, it was assumed that 259 
this would speed up the detection of both stage 1 and 2 cases, and lead to less underreporting.  260 
At present, no published study has yet ascertained the quantitative impact of this type of 261 
enhanced screening upon the detection rate. The single (unstaged) data point in 2015 is 262 
unfortunately insufficient to generate robust estimates here. Therefore model predictions 263 
generate approximations for the qualitative change that would be anticipated under the model 264 
by doubling the passive detection and reporting rates for 2015 onwards. 265 
The model provides estimates for the decline in new infections, but also the predicted impact 266 
of both medical and vector controls on future HAT reporting and transmission. Counterfactual 267 
model simulations with medical interventions but no vector control were conducted to 268 
establish the expected impact that active and passive screening would have had in the absence 269 
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of vector interventions. The predictions were used to establish the feasibility of achieving 270 
elimination as a public health problem, defined as less than 1 reported case per 10,000 people, 271 
by 2020. This mathematical modelling analysis was conducted using Matlab software. Further 272 
model details can be found in the SI. 273 
 274 
 275 
Results 276 
 277 
Human population 278 
A total of 114 human settlements were identified and recorded, comprising 22 encampments 279 
(<100 inhabitants), 70 hamlets (100 – 500 inhabitants) and 27 villages (>500 inhabitants) (Fig 280 
2). Out of the 38 674 inhabitants counted, 1029 were located in encampments, 17 629 in 281 
hamlets, and 20 016 in villages. Therefore, in the intervention area (840 km2), the human 282 
population density can be estimated to be around 46 inhabitants per square kilometre. The 283 
networks of tracks between settlements and towards the swamp were recorded as well as and 284 
the main crossing tracks in the swamp (Fig 2, S1_Fig). 285 
 286 
Figure 2. Location of the study area and distribution of human population, tsetse flies and tiny 287 
targets in the study area. This map shows the entire Mandoul focus, with the Mandoul river in 288 
blue.   Target deployment started in the middle (just before the river separation in 3 branches) 289 
and the targets were mainly deployed on the two left branches. 290 
 291 
T0 survey and targets deployment 292 
A total of 145 tsetse were caught by the 108 biconical traps during the T0 survey, all 293 
belonging to G. f. fuscipes, with 50 males (34.5%) and 95 females (65.5%). Apparent density 294 
in the whole area was 0.65 tsetse/trap/day, ranging from 0 to 26 tsetse/trap/day. Out of the 295 
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108 traps, 22 (20.4%) caught tsetse and they were all located on the two main branches of the 296 
Mandoul River (Fig 2). 297 
For the first deployment in 2014, 2600 targets were deployed on both sides of the river and its 298 
tributaries. These targets were replaced one year later with new ones along with an extra 108 299 
additional targets, in order to improve the area coverage (Fig 2), giving a total number of 300 
2708 targets. Out of the 840 km2 of the intervention area of the Mandoul focus, the actual area 301 
on which targets were deployed represents 45 km2, corresponding to the gallery surrounding 302 
the portion of the Mandoul River where tsetse were found. Hence the overall target density 303 
can be calculated either as 3.2 targets/km2 if based on the whole intervention area, or 60 304 
targets per linear km if only considering the riverine system. 305 
 306 
Impact of tiny targets on tsetse densities 307 
The total catch of tsetse from 44 sentinel traps was 145 tsetse (1.62 flies/trap/day). At the first 308 
evaluation post target deployment (T1, 2 months later), only 2 tsetse were caught (0.02 309 
tsetse/trap/day) were observed (Figure 3). The same density was again observed during the 310 
second evaluation (T2) but thereafter no tsetse was caught during the next three successive 311 
surveys (T3-T6), even with the additional traps and sticky traps deployed to increase the 312 
probability of capture. During the sixth survey (T6, October 2015), trapping duration was 313 
extended to six consecutive days and one tsetse was caught. No tsetse were caught during the 314 
three surveys conducted in 2016 (T7-T9). 315 
 316 
Statistical analysis using GMLE resulted in two selected models differing by only one effect 317 
(see SI for more detailed results). The best model had only location specific baselines, the 318 
pre-target deployment indictor (p<10-18, coeff=5.3 i.e. a predicted 99.5% reduction due to tiny 319 
target intervention) and an overdispersion effect. The other selected model also included a 320 
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precipitation fixed effect, but the pre-target deployment indicator remained strongly 321 
significant (p<10-11, coeff=5.4). 322 
 323 
 324 
Figure 3: Impact of tiny targets on catch of tsetse. Black box and whiskers (with outliers 325 
shown as circles) show the numbers of tsetse caught per trap during each entomological 326 
survey (T0-T9). When no tsetse were caught during a survey, boxes appear as horizontal bars. 327 
Red bars indicate deployment of tiny targets.    328 
 329 
Modelling the impact of tiny targets on new HAT infections 330 
Model fitting to human case data indicates that active screening has played a major role in the 331 
reduction of new HAT infections between 2000 and 2013. Over this time there is an estimated 332 
71.5% (95% CI: 67–75%) reduction in new transmissions (see Fig 4). This trend is not so 333 
apparent in the detected HAT cases due to high fluctuation in screening levels during that 334 
time period, leading to a variable detection rate. Despite this ambiguity, it is noted that from 335 
2009 onwards, detected cases remained at relatively low levels despite annual screening at 336 
moderate levels (see Fig 5). It is seen that passive screening plays a variable role in case 337 
detection, and the model can capture this trend. For example with more cases being detected 338 
by passive surveillance in 2008 following no active screening in 2007/2008.  339 
To assess the robustness of model predictions, an additional fit was performed using only 340 
epidemiological data for 2000–2006, and used 2007–2013 as validation years without vector 341 
control and 2014–2014 as validation years with vector control. The model dynamics obtained 342 
were very similar to those presented here, despite using only the first half of the data set (see 343 
SI S2.2 for detailed analysis). 344 
Projecting 2014 and 2015 was performed using four different strategies: (1) basic medical, 345 
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using known levels of active screening and assuming passive detection continued unchanged 346 
in 2015, (2) improved medical, using known active screening and assuming passive detection 347 
and reporting rates doubled in 2015, (3) basic medical and vector control, the same as basic 348 
medical with vector control from 2014, and (4) improved medical and vector control, the 349 
same as improved medical with vector control from 2014. Strategy 4 represents the strategy 350 
that occurred in 2014–2015 and is coloured purple in Figs 4 and 5. It is seen that, using the 351 
actual strategy, the model captures the trend in reported cases for 2014/2015. Comparing 352 
these years to the counterfactual strategies (1–3) predictions demonstrates the additional 353 
benefit of having added tsetse control and/or enhanced passive surveillance to the existing 354 
medical intervention. 355 
Mathematical modelling estimates that, without vector control, there would have been 129 356 
(95% CI, 105-157) and 123 (95% CI, 97-150) cases per year in 2014 and 2015 respectively 357 
with the reduction due to active screening. In reality only 90 and 47 cases were observed (in 358 
2014 and 2015) when a combined vector and enhanced medical strategy took place; in 2013 359 
there were 186 cases. Modelling results indicate that 29.6% (95% CI: 5 - 49%) of this two-360 
year decline was through active screening, and the remaining 70.4% (95% CI: 51-95%) was 361 
due to vector control. In 2015, the new passive strategy was predicted to result in slightly 362 
more case reporting than the basic medical strategy and so was not attributed to this particular 363 
decline. 364 
 365 
Likewise, new infections are calculated to have fallen dramatically. The model surmises that 366 
transmission fell from around 311 new infections per year in 2013 to a mean of 7 and 0 new 367 
infections per year in 2014 and 2015 respectively. Over these two years, 28.7% (95% CI: 25–368 
33%) of this decline is attributed to active screening, 8.5% (95% CI: 8–9%) to passive and 369 
62.8% (95% CI: 59–66%) to vector control.    370 
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 371 
Projecting forwards to 2020 using the model gives an optimistic forecast if vector control and 372 
screening continue at the 2015 level. Continuing this combined strategy is predicted to result 373 
in fewer than 2 annually reported cases and zero transmission in 2020; this strategy appears 374 
sufficient to reach elimination as a public health problem by 2018 and full elimination over a 375 
decade in advance of the WHO 2030 goal. It is noted that the model predicts this will occur 376 
with or without enhanced passive screening. Under the counterfactual strategy without vector 377 
control, the reported cases and transmission may have continued to decline steadily, reaching 378 
around 47 (95% CI: 31-67) reported cases in 2020 without enhanced passive screening; 379 
although this would have still been substantially higher than the 3.9 reported cases threshold 380 
that is necessary to achieve elimination as a public health problem in the focus. Results from 381 
the counterfactual strategy without vector control but with enhanced passive detection, 382 
predicted that there would have been even fewer reported cases compared to the basic medical 383 
strategy, with 20 (95% CI: 7–25) reported cases in 2020, however this would still be above 384 
the target threshold. 385 
 386 
 387 
Figure 4. Inferred level of underlying transmission from modelling. The grey box plots show 388 
the estimated numbers of new infections in humans for each year (2000–2013). Coloured 389 
boxes denote the predicted number of new infections from 2014 onwards under four different 390 
strategies including combinations of either basic or enhanced medical strategies and vector 391 
control. Improved medical strategies had increases to the passive detection and reporting rates 392 
from 2015, whilst vector control strategies began in 2014. Purple boxes denote the strategy 393 
that took place with both improvements to passive screening and tsetse control. 394 
 395 
	 17	
Figure 5. Model fit to data. The top graph shows the annual level of active screening achieved 396 
in the focus. The middle and bottom graphs show the observed active and passive case 397 
detections as a solid grey line with the model fit (years 2000–2013) displayed as grey box and 398 
whisker plots. The model projections of the four strategies for 2014 onwards are shown as 399 
coloured box plots and include combinations of either basic or enhanced medical strategies 400 
and vector control. Improved medical strategies had increases to the passive detection and 401 
reporting rates from 2015, whilst vector control strategies began in 2014. Purple boxes denote 402 
the strategy that took place with both improvements to passive screening and tsetse control. 403 
 404 
Discussion 405 
This study shows that adding tsetse control to the ‘screen and treat’ strategy had a marked 406 
impact on the transmission of sleeping sickness in the Mandoul focus. This echoes the recent 407 
findings from Guinea where tsetse control also resulted in a significant decrease of the 408 
incidence of HAT [3]. 409 
The total number of cases diagnosed and treated (1143 cases since 2009 out of a population of 410 
38 674 people) suggests that up to 3.0% of the people in this area have had sleeping sickness. 411 
A huge medical effort was conducted in this focus with 142 467 people being screened 412 
between 2009 and 2015. Given the population number is ~38 674, it means that on average, 413 
every individual in the area was screened nearly four times during this period. Despite this 414 
effort, a substantial decrease in HAT reporting occurred only when vector control was added 415 
to the medical strategy. In 2014, there was a decrease in the stage 1 to stage 2 detection ratio 416 
for both active and passive surveillance. For active screening this ratio was 1.5 stage 1 cases 417 
for every stage 2 case which decreased from 2.7 in 2012 and 2013 when a similar level of 418 
active screening was achieved. For passive surveillance there were 0.16 stage 1 cases per 419 
stage 2 case in 2014, which decreased from 0.22 and 0.24 in 2012 and 2013 respectively. This 420 
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relative decline in the stage 1 to stage 2 case ratio supports the hypothesis that vector control 421 
has reduced new transmissions, and is expected to continue to decline over the coming years 422 
whilst tsetse control remains in place, although the improved passive surveillance that began 423 
in 2015 could skew this ratio. Modelling supports the assertion that tsetse control has greatly 424 
impacted past reporting and transmission, and will continue to do so whilst the fly population 425 
remains supressed. 426 
It is acknowledged that there are several assumptions that effect the results generated by the 427 
mathematical modelling results presented here, many of which have been discussed elsewhere 428 
[21, 22]. Given the relatively small size of the Mandoul focus, it is unlikely that spatial effects 429 
would alter the presented results, however temporal heterogeneities arising from unknown 430 
dates of screenings could explain some of the discrepancies between reported HAT cases and 431 
model outputs. Furthermore, the dynamic model does not take importations from other areas 432 
into account, which could result in other small differences between the model and data. By 433 
additional analysis which used 2007–2015 as validation years (see SI), the model seems to 434 
perform well at mid-range prediction, providing evidence for the model’s forecasting ability 435 
and justification for its use here as a tool to evaluate intervention strategies. 436 
 437 
One particular challenge was to estimate the impact of new enhanced medical strategies, 438 
which began in the region in 2015, on case detection and reporting. Unfortunately there was 439 
little information with which to accurately parameterise the mathematical model to account 440 
for this change in strategy, although the presented results demonstrate the expected qualitative 441 
impact that this has had, and should continue to have, in Mandoul. The modelling results 442 
demonstrate that it very possible that improved screening actually increased the number of 443 
passively detected cases in 2015, but would be expected to lead to reduced cases in 444 
subsequent years by reducing transmission. As there was uncertainty surrounding this 445 
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strategy, results without improved screening were also shown for comparison. Future work 446 
using other data sets could help to better inform model parameterisation of this type of 447 
enhanced medical strategy. 448 
 449 
For vector control, the lack of a control (non-intervention) area is a limitation for the study. 450 
However, the aim of the intervention was to protect the people of Mandoul from sleeping 451 
sickness. This is an isolated focus without a comparable area, which could have served as an 452 
appropriate control. In the absence of a control, empirical data, gathered before and after 453 
entomological intervention, has been used in conjunction with models to estimate its relative 454 
impact. 455 
 456 
The vector in the Mandoul area is G. f. fuscipes as reported previously [23]. G. morsitans 457 
submorsitans was captured by surveys conducted 20 years ago [11], but none was caught 458 
during the current surveys, or previous ones in the area [23]. This confirms its disappearance 459 
in places where human encroachment is high and where wildlife disappears, as reported 460 
elsewhere [24, 25]. 461 
In the Mandoul focus, the medical ‘screen and treat’ strategy saved many lives but the 462 
addition of vector control has driven the incidence to even lower levels (0.38%) and this may 463 
have interrupted transmission of T. brucei gambiense. Why was this incidence not achieved 464 
without vector control? Among several possible causes, the geographical situation and human 465 
behaviour in this area may be a key parameter, especially human mobility. The human 466 
population frequently crosses the tsetse-infested swamp. The population between the two 467 
banks come from the same ethnic group and often belong to the same families. It means that 468 
for any social event, people need to cross the swamp. Moreover, there is an important local 469 
market and facilities (healthcare, veterinary, school, local government) in the town of Bodo 470 
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which is visited frequently by local people, many of whom must cross the swamp to reach 471 
Bodo. 472 
The rapid and drastic decrease in catch of tsetse suggests that tiny targets can control G. f. 473 
fuscipes in this setting. The small size of the area, well defined with limited habitat for tsetse 474 
and its relative isolation with low reinvasion pressure may have contributed to the success of 475 
the intervention. This contrasts with two other foci where tiny targets have been recently used 476 
to control tsetse. In the Boffa focus of Guinea, extensive and difficult-to-access mangrove 477 
made vector control (G. palpalis there) much more difficult [5, 26]. Similarly in the Arua 478 
focus of northern Uganda, the widely distributed population of G. f. fuscipes was not driven to 479 
the low (i.e., close to zero) levels seen in Chad [8]. 480 
Present results further demonstrate the efficacy of combining medical interventions with 481 
vector control to halt T. b. gambiense transmission, in certain epidemiological settings. Unlike 482 
medical interventions, which reduce disease duration and consequently decrease the number 483 
of new infections, tsetse control directly prevents people from becoming infected. As neither 484 
vaccine nor chemoprophylaxis for HAT exist this provides a valuable protective tool. As in 485 
Chad, Uganda and Guinea, this strategy can be applied in other foci where HAT still exists 486 
despite medical surveys and treatment of cases. While the use of tiny targets was effective in 487 
this operation, other methods may be appropriate elsewhere. For instance, many cattle are 488 
present in Mandoul. These animals, owned by sedentary farmers and more mobile 489 
pastoralists, are at risk of animal African trypanosomiasis [23] and hence controlling tsetse, 490 
using targets and/or treating cattle with insecticide, will also have a positive consequence on 491 
both animal and human health. This means that with minimal additional efforts, expanding 492 
this one health approach could benefit to people and their animals in this area, as certainly in 493 
other areas of the same type [27]. 494 
 495 
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